Eagle's Eye View: Your Weekly CV Update From ACC.org

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane review the late-breaking clinical trials from Day 2, Sunday, April 6 at the American College of Cardiology Scientific Sessions 2024 in Atlanta. Trials on Sunday include REDUCE-AMI (0:35), DanGer-Shock (3:28), ULTIMATE-DAPT (6:17) and TACT2 (10:04). For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #ACC24.  Subscribe to Eagle’s Eye View    

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane review the late-breaking clinical trials from Day 1, Saturday, April 5 at the American College of Cardiology Scientific Sessions 2024 in Atlanta. Trials on Saturday include AEGIS II (0:45), VICTORION-INITIATE (2:36), RELIEVE-HF (5:27) and Step-HFpEF Dm (8:42). For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #ACC24.  Subscribe to Eagle’s Eye View    

In this week’s View, Dr. Eagle looks at the timing of complete multivessel revascularization in patients presenting with non-ST-Elevation Acute Coronary Syndrome, then examines the accuracy of wearable heart rate monitors during exercise in sinus rhythm and atrial fibrillation. Finally, Dr. Eagle shares some thoughts on a multinational observation study on sports-related sudden cardiac death.  Subscribe to Eagle’s Eye View    

In this special edition of Eagle’s Eye View, Dr. Eagle highlights the latest science and innovation being presented at ACC.24 in Atlanta, Georgia from April 6-8. He gives us valuable insights into practice-changing updates in care. The topics include late-breaking clinical trials and science focusing on new drugs and device therapies.  Tune into ACC.org’s coverage of ACC.24 to hear from the top experts as they debate, discuss the results of the trials, share visual abstracts and find out how it all fits into your practice. The transformation of care begins at ACC.24.  Subscribe to Eagle’s Eye View 

In this week’s View, Dr. Eagle looks at sacubitril/valsartan in patients hospitalized with decompensated heart failure, then examines the prevalence and outcomes of patients with discordant high gradient aortic stenosis. Finally, Dr. Eagle shares some thoughts on current concepts regarding transcatheter treatment of tricuspid valve regurgitation.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI. He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis. Finally, Dr. Eagle discusses four studies comparing percutaneous coronary intervention versus coronary artery bypass grafting in patients with left main disease with or without diabetes.  Subscribe to Eagle’s Eye View  

This podcast delves into blood pressure parameters predicting peripheral arterial disease (PAD), five-year outcomes of leadless pacemakers, and the role of palliative care in heart failure treatment. Insights include analyzing ankle blood pressure indices, challenges in palliative care, and upcoming clinical trials in heart failure management.

This week, Dr. Eagle dedicates this episode of Eagle’s Eye View to JACC and the upcoming special issue of the Journal edited by Dr. Fuster. Dr. Eagle comments cover JACC articles on lipoprotein(a) and major adverse cardiovascular events in patients with or without baseline atherosclerotic cardiovascular disease, then explores intraoperative anemia and how it mediates sex disparity in operative mortality after coronary artery bypass grafting. Finally, Dr. Eagle talks about the value of surveillance stress testing after percutaneous intervention for patients with multivessel or left main coronary disease.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle covers coronary calcium scores and how they predict ASCVD risk in the presence of left main disease and diabetes. He then explores TRI-SCORE and the benefits of intervention in patients with severe tricuspid regurgitation. Finally, Dr. Eagle talks about booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle covers opportunities in the postpartum period to reduce cardiovascular disease risk after adverse pregnancy outcomes. He then explores the apparent increased risk of myocardial infarction, heart failure and atrial fibrillation after spinal cord injury. Finally, Dr. Eagle talks about a systematic review and network meta-analysis of coronary angiography, intravascular ultrasound, and optical coherence tomography in the guidance of percutaneous coronary intervention.  Subscribe to Eagle’s Eye View